Telehealth firms prescribe GLP-1s off-label for addiction ahead of FDA approval
STAT reports that some addiction telehealth platforms now market branded and compounded GLP-1s for alcohol use disorder. Experts warn of fragmented care.
Recap by typeshit. Full story at STAT.